Profit from Aurigon’s long-standing expertise in the development of small molecules

For more than 30 years our scientists are gaining expert knowledge in the development of chemical compounds into pharmaceutical products. With a vita combining academic research, big pharma drug development experience and client oriented service performance, they are the perfect partner for testing of small molecules with challenging chemico-physical properties.

Our facilities and services cover all requirements of the non-clinical testing of NCEs:

• Pharmaco- and toxicokinetic sample measurement including statistical evaluation with acknowledged and validated tools (WinNonLin, SAS)
• Studies performed according to the latest FDA, EMA, ICH and OECD guidelines
• GLP-compliant animal houses, quality assurance and audit reports for all GLP-compliant studies
• Multiple modes of administration (incl. long-term infusion, s.c. osmotic mini-pump, transdermal)
• Animal handling according to the 2010/63/EU guideline and under the control of the Institutional Animal Care and Use Committee

Explore our special services for the pharmaceutical development of small molecules:

• Expertise in the bioanalytical support of clinical trials I to IV
• Expert data interpretation: dosimetry calculation for human metabolic study and FIM dose prediction

---